Segments - Amblyopia Treatment Market by Treatment Type (Spectacle Lenses, Eye Patches, Eye Drops & Ointments, Surgery, and Others), Distribution Channel (Pharmacies, Hypermarkets & Supermarkets, Drug Store, E-commerce, and Others), End-user (Hospitals, Clinical Laboratories, Physician Offices, Reference Laboratories, and Others) and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global amblyopia treatment market size was USD 3.8 Billion in 2023 and is projected to reach USD 5.46 Billion by 2032, expanding at a CAGR of 4.1% during 2024–2032. The market growth is attributed to the growing demand for amblyopia treatment solutions.
Increasing awareness about the importance of early intervention in vision disorders is resulting in the growing demand for amblyopia treatments, which further boosts the market. These treatments are increasingly utilized in vision recovery centers, eye hospitals, and telemedicine platforms, catering to a diverse consumer base. Furthermore, a growing number of people experiencing vision impairments propels the market during the forecast period.
According to the report published by WHO on August 10, 2023, around 2.2 billion individuals are suffering from distance vision impairment globally.
The use of artificial intelligence is likely to boost the amblyopia treatment market. AI-powered algorithms analyze vast amounts of patient data to identify subtle patterns and indicators of amblyopia with accuracy. Furthermore, AI-enabled telemedicine platforms have expanded access to amblyopia care, particularly in underserved areas, by facilitating remote consultations and monitoring.
Increasing prevalence of amblyopia is anticipated to drive the market during the forecast period. Factors such as excessive screen time and changing lifestyles create a need for effective treatment solutions for eye disorders. For instance, as per the report published by the National Eye Institute on September 22, 2022, amblyopia is a vision disorder that typically begins in childhood and affects up to 3 out of every 100 children globally. Moreover, government initiatives aimed at promoting early diagnosis and intervention are expected to further fuel the demand for amblyopia treatment in the coming years.
High treatment costs are anticipated to hinder the market during the forecast period. The cost of amblyopia treatment includes expenses related to consultations with ophthalmologists, diagnostic tests, such as visual acuity testing, and imaging studies. Moreover, the limited accessibility to specialized healthcare facilities and trained professionals for amblyopia in remote location further hampers the market.
Rising investment in research and development (R&D) activities is expected to create immense opportunities for the players competing in the market in the coming years. Manufacturers are aiming to allocate substantial resources toward the development of innovative apparatus technologies and modalities for amblyopia. Furthermore, the integration of telehealth and remote monitoring in these devices to treat remotely is boosting the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes |
Details |
Report Title |
Amblyopia Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017 -2022 |
Forecast Period |
2024–2032 |
Segmentation |
Treatment Type (Spectacle Lenses, Eye Patches, Eye Drops & Ointments, Surgery, and Others), Distribution Channel (Pharmacies, Hypermarkets & Supermarkets, Drug Store, E-commerce, and Others), and End-user (Hospitals, Clinical Laboratories, Physician Offices, Reference Laboratories, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
3M; Good-Lite Co; Healio; HOYA; Johnson & Johnson Services, Inc; Lancastle International Ltd; NovaSight; Ortopad USA.Com; RevitalVision; Trayner Staffing LLC; and Vivid Vision, Inc. |
In terms of region, the global amblyopia treatment market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to the well-established healthcare systems and increasing initiatives to promote early diagnosis & treatment of amblyopia. Moreover, the rising population suffering from vision impairments in this region further boosts the demand for amblyopia treatments in various healthcare settings.
According to a report published by the Centers for Disease Control and Prevention on December 19, 2022, around 12 million the US-citizens aged 40 years or older are suffering with vision impairment. Furthermore, nearly 6.8% of children under 18 in the US have been diagnosed with eye and vision conditions.
The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to improved access to healthcare services, such as amblyopia treatment solutions. Furthermore, increasing healthcare access in rural areas, and promoting diagnosis and treatment of vision disorders are anticipated to fuel the market in the region during the forecast period.
Based on treatment type, the amblyopia treatment market is divided into spectacle lenses, eye patches, eye drops & ointments, surgery, and others. The eye patches segment held a major share of the market in 2023, due to their widespread adoption as a standard treatment modality for amblyopia, especially in pediatric patients.
Eye patches are commonly used to occlude the stronger eye, thereby encouraging the weaker eye to function and develop properly. Moreover, the non-invasive nature of occlusion therapy and its minimal side effects further boost their demand.
The eye drops & ointments segment is expected to expand at a significant growth rate in the coming years, owing to the advancements in pharmacological interventions and the introduction of innovative treatment options. Pharmaceutical companies are increasingly focusing on developing novel formulations, targeting specific mechanisms underlying amblyopia pathogenesis such as visual cortex plasticity and neurotransmitter regulation. Moreover, the convenience and efficacy of pharmacological treatments are likely to appeal to both patients and healthcare providers, thereby fueling the adoption of eye drops and ointments.
On the basis of distribution channel, the global market is segregated into pharmacies, hypermarkets & supermarkets, drug store, e-commerce, and others. The e-commerce segment is anticipated to expand at a substantial CAGR during the forecast period, as they offer unparalleled convenience, allowing patients to browse, purchase, and receive products from the comfort of their homes. Moreover, the expansive reach of e-commerce platforms enables patients in remote or underserved areas to access diverse amblyopia treatment options. These factors further boost the segment during the forecast period.
On the basis of end-user, the market is divided into hospitals, clinical laboratories, physician offices, reference laboratories, and others. The hospitals segment generated a major revenue share of the market in 2023, due to their advanced infrastructure and access to specialized ophthalmic equipment and expertise. Furthermore, hospitals often serve as referral centers for complex cases of amblyopia, attracting patients seeking specialized care and advanced treatment options. These all factors contributes to the growing demand for amblyopia treatment in these types of healthcare settings.
The physician offices segment is expected to lead the market in terms of revenue during the projection period, owing to the growing patient pool towards these type of healthcare settings. Physician offices offer accessible and personalized amblyopia care experience for patients. Moreover, the growing emphasis on preventive care and early intervention in vision disorders is likely to boost the demand for amblyopia treatment in physician offices.
The amblyopia treatment market has been segmented on the basis of
Key players competing in the global amblyopia treatment market are 3M; Good-Lite Co; Healio; HOYA; Johnson & Johnson Services, Inc; Lancastle International Ltd; NovaSight; Ortopad USA.Com; RevitalVision; Trayner Staffing LLC; and Vivid Vision, Inc
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide. For instance,
On October 24, 2022, Healio, a medical equipment manufacturer, received clearance from FDA 510(k) for its digital therapy devices for amblyopia. These treatment glasses are meant to replace traditional eye patching and are used in home settings. The technology uses eye-tracking to train both eyes to work together.